Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Aug 03 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-03-2023-7

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 03, 2023, titled "Zydus receives Final Approval from the USFDA for Indomethacin Suppository with Competitive Generic Therapy (CGT) designation".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases